Skip to main content
Equibles

MetLife Investment Management, LLC

Position in MYGN — Myriad Genetics Inc

CIK 1529735 Whippany, NJ
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$315,974
+$95,938 QoQ
Shares Held
55,337
+13.2% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#87
of 196 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MetLife Investment Management, LLC holds $164,155,372 across 29 Diagnostics & Research names. MYGN ranks #27 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TMO
Thermo Fisher Scientific Inc.
 85,023 $42,627,131
2 DHR
Danaher Corp /De/
 144,142 $27,456,168
3 ILMN
Illumina, Inc.
 72,858 $12,810,622
4 IDXX
Idexx Laboratories Inc /De
 20,659 $10,875,723
5 A
Agilent Technologies, Inc.
 64,648 $8,587,193
6 WAT
Waters Corp /De/
 22,466 $8,425,648
7 IQV
Iqvia Holdings Inc.
 38,172 $7,375,593
8 MEDP
Medpace Holdings, Inc.
 11,779 $6,238,040

All Filings in MYGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $315,974 55,337
2026-03-31 $220,036 48,897
2025-12-31 $264,050 42,935
2025-09-30 $385,171 53,274
2025-06-30 $285,566 53,779
2025-03-31 $482,359 54,381
2024-12-31 $753,104 54,931
2024-09-30 $1,416,063 51,700
2024-06-30 $1,264,582 51,700
2024-03-31 $938,229 44,007
2023-12-31 $816,684 42,669
2023-09-30 $684,410 42,669
2023-06-30 $989,067 42,669
2023-03-31 $991,200 42,669
2022-12-31 $619,127 42,669
2022-09-30 $814,124 42,669
2022-06-30 $775,295 42,669
2022-03-31 $1,075,258 42,669
2021-12-31 $756,626 27,414
2021-09-30 $885,198 27,414
2021-06-30 $838,320 27,414
2021-03-31 $834,756 27,414
2020-12-31 $628,962 31,814
2020-09-30 $414,854 31,814
2020-06-30 $360,770 31,814
2020-03-31 $455,258 31,814